Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Not yet recruiting 1

Sponsor Class

NIH 2OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Classical hematology 1

Conditions

Breast Neoplasms 341Neoplasms 247Prostatic Neoplasms 196Colorectal Neoplasms 147Lung Neoplasms 133Carcinoma, Non-Small-Cell Lung 113Leukemia, Myeloid, Acute 108Pancreatic Neoplasms 99Multiple Myeloma 90Precursor Cell Lymphoblastic Leukemia-Lymphoma 77Brain Neoplasms 74Glioblastoma 70Head and Neck Neoplasms 69Carcinoma, Hepatocellular 67Squamous Cell Carcinoma of Head and Neck 62Melanoma 60Neoplasm Metastasis 56Uterine Cervical Neoplasms 55Ovarian Neoplasms 54Rectal Neoplasms 51Stomach Neoplasms 49Hematologic Neoplasms 48Myelodysplastic Syndromes 45Carcinoma, Renal Cell 45Recurrence 43Motor Activity 43Glioma 43Triple Negative Breast Neoplasms 42Esophageal Neoplasms 40Lymphoma, Non-Hodgkin 39

Interventions

Vancomycin 1Teicoplanin 1Ofloxacin 1Metronidazole 1Meropenem 1Ciprofloxacin 1Ceftazidime 1Cefepime 1Amikacin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Neutropenia × 30 days × Clear all
NCT07590648 2026-05-15

E-STOP2

Hospital Universitari Vall d'Hebron Research Institute

Phase 4 Not yet recruiting
136 enrolled
Classical hematologyOther hematologic neoplasm

Neoplasms, Neutropenia, Hematologic Neoplasms, Febrile Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡